Clinical and immunological markers of dengue progression in a study cohort from a hyperendemic area in Malaysia

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Rathakrishnan, Anusyah ^a   Klekamp, Benjamin ^b,g   Wang, Seok Mui ^c   Komarasamy, Thamil Vaani ^a   Natkunam, Santha Kumari ^d   Sathar, Jameela ^e   Azizan, Azliyati ^b   Sanchez Anguiano, Aurora ^b   Manikam, Rishya ^f   Sekaran, Shamala Devi ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITI TEKNOLOGI MARA   (Malaysia)

^d Hospital Tengku Ampuan Rahimah   (Malaysia)

^e Ampang Hospital   (Malaysia)

^f UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^g Department of Health ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYTOKINE; DNA; HLA A ANTIGEN; HLA B ANTIGEN; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 2; NONSTRUCTURAL PROTEIN 2A; NONSTRUCTURAL PROTEIN 4A; NONSTRUCTURAL PROTEIN 4B; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; GAMMA INTERFERON; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CLOTTING TIME; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DENGUE; DISEASE COURSE; DISEASE SEVERITY; DNA EXTRACTION; FEMALE; HLA TYPING; HOSPITAL; HUMAN; HUMAN CELL; IMMUNOLOGICAL PARAMETERS; INDIAN; INFORMED CONSENT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALAYSIA; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; SYMPTOM; THROMBOCYTOPENIA; VERY ELDERLY; CASE CONTROL STUDY; COMORBIDITY; DEMOGRAPHY; DENGUE VIRUS; ENDEMIC DISEASE; GENE FREQUENCY; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; REPRODUCIBILITY; STATISTICS AND NUMERICAL DATA; T LYMPHOCYTE; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; COMORBIDITY; DEMOGRAPHY; DENGUE; DENGUE VIRUS; DISEASE PROGRESSION; ENDEMIC DISEASES; FEMALE; GENE FREQUENCY; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; IMMUNOGLOBULIN M; INTERFERON-GAMMA; MALAYSIA; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84898670867     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092021     Document Type: Article

References (59)

1. WHO WHO (2010) Western pacific country health information profiles: 2010 revision. Geneva: World Health Organization.
2. Beatty ME, Stone A, Fitzsimons DW, Hanna JN, Lam SK, et al. (2010) Best Practices in Dengue Surveillance: A Report from the Asia-Pacific and Americas Dengue Prevention Boards. PLoS Negl Trop Dis 4: e890.
3. WHO WHO (2009) Dengue guidelines for diagnosis, treatment, prevention and control : new edition. Geneva: World Health Organization. x, 147 p. p.
4. Vinomarlini G, Rogayah T, Saraswathy TS, Thayan R, Apandi M, et al. (2011) Molecular typing of dengue viruses circulating on the East Coast of Peninsular Malaysia from 2005 to 2009. Southeast Asian J Trop Med Public Health 42: 94-99.
5. Suaya JA, Shepard DS, Siqueira JB, Martelli CT, Lum LCS, et al. (2009) Cost of Dengue Cases in Eight Countries in the Americas and Asia: A Prospective Study. The American Journal of Tropical Medicine and Hygiene 80: 846-855.
6. Halstead SB (2012) Controversies in dengue pathogenesis. Paediatr Int Child Health 32 Suppl 1: 5-9.
7. Halstead S (1980) Dengue haemorrhagic fever-a public health problem and a field for research. Bulletin of the World Health Organization 58: 1.
8. Simmons CP, Dong T, Chau NV, Dung NTP, Chau TNB, et al. (2005) Early Tcell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections. Journal of Virology 79: 5665-5675. (Pubitemid 40548235)
9. Appanna R, Huat TL, See LL, Tan PL, Vadivelu J, et al. (2007) Cross-reactive T-cell responses to the nonstructural regions of dengue viruses among dengue fever and dengue hemorrhagic fever patients in Malaysia. Clin Vaccine Immunol 14: 969-977.
10. Priyadarshini D, Gadia RR, Tripathy A, Gurukumar KR, Bhagat A, et al. (2010) Clinical findings and pro-inflammatory cytokines in dengue patients in Western India: a facility-based study. PLoS One 5: e8709.
11. Bozza FA, Cruz OG, Zagne SM, Azeredo EL, Nogueira RM, et al. (2008) Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis 8: 86.
12. Mathew A, Rothman AL (2008) Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunol Rev 225: 300-313.
13. Yong YK, Thayan R, Chong HT, Tan CT, Sekaran SD (2007) Rapid detection and serotyping of dengue virus by multiplex RT-PCR and real-time SYBR green RT-PCR. Singapore Med J 48: 662-668. (Pubitemid 351396798)
14. Lam SK, Devi S, Pang T (1987) Detection of specific IgM in dengue infections. Southeast Asian J Trop Med Pub Health 18: 532-538.
15. Clarke DH, Casals J (1958) Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg 7: 561- 573.
16. Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR (2011) Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 39: D913-919.
17. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S (1999) SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50: 213-219. (Pubitemid 30099526)
18. Reche PA, Glutting JP, Reinherz EL (2002) Prediction of MHC class I binding peptides using profile motifs. Hum Immunol 63: 701-709. (Pubitemid 34983301)
19. Rathakrishnan A, Wang SM, Hu Y, Khan AM, Ponnampalavanar S, et al. (2012) Cytokine expression profile of dengue patients at different phases of illness. PLoS One 7: e52215.
20. Anker M, Arima Y (2011) Male-female differences in the number of reported incident dengue fever cases in six Asian countries. Western Pacific Surveillance and Response Journal 2: 17-23.
21. Lee LK, Thein TL, Kurukularatne C, Gan V, Lye DC, et al. (2011) Dengue knowledge, attitudes, and practices among primary care physicians in Singapore. Ann Acad Med Singapore 40: 533-538.
22. Dussart P, Baril L, Petit L, Beniguel L, Quang LC, et al. (2012) Clinical and virological study of dengue cases and the members of their households: the multinational DENFRAME Project. PLoS Negl Trop Dis 6: e1482.
23. Muhammad Azami NA, Salleh SA, Neoh HM, Syed Zakaria SZ, Jamal R (2011) Dengue epidemic in Malaysia: Not a predominantly urban disease anymore. BMC Res Notes 4: 216.
24. Ang KT, Rohani I, Look CH (2010) Role of primary care providers in dengue prevention and control in the community. Med J Malaysia 65: 58-62.
25. Srikiatkhachorn A, Green S (2010) Markers of dengue disease severity. Curr Top Microbiol Immunol 338: 67-82.
26. Hottz E, Tolley ND, Zimmerman GA, Weyrich AS, Bozza FA (2011) Platelets in dengue infection. Drug Discovery Today: Disease Mechanisms 8: e33-e38.
27. Matsuura C, Moraes TL, Barbosa JB, Moss MB, Siqueira MA, et al. (2012) Nitric oxide activity in platelets of dengue haemorrhagic fever patients: the apparent paradoxical role of ADMA and l-NMMA. Trans R Soc Trop Med Hyg 106: 174-179.
28. Kuo CH, Tai DI, Chang-Chien CS, Lan CK, Chiou SS, et al. (1992) Liver biochemical tests and dengue fever. Am J Trop Med Hyg 47: 265-270.
29. Kalayanarooj S, Nimmannitya S (2003) Clinical presentations of dengue hemorrhagic fever in infants compared to children. J Med Assoc Thai 86 Suppl 3: S673-680. (Pubitemid 38009759)
30. Chaturvedi UC, Nagar R, Shrivastava R (2006) Dengue and dengue haemorrhagic fever: implications of host genetics. FEMS Immunology & Medical Microbiology 47: 155-166. (Pubitemid 43881735)
31. McNicholl J (1998) Host genes and infectious diseases. Emerg Infect Dis 4: 423-426.
32. Nguyen TP, Kikuchi M, Vu TQ, Do QH, Tran TT, et al. (2008) Protective and enhancing HLA alleles, HLA-DRB1*0901 and HLA-A*24, for severe forms of dengue virus infection, dengue hemorrhagic fever and dengue shock syndrome. PLoS Negl Trop Dis 2: e304.
33. Appanna R, Ponnampalavanar S, Lum Chai See L, Sekaran SD (2010) Susceptible and protective HLA class 1 alleles against dengue fever and dengue hemorrhagic fever patients in a Malaysian population. PLoS One 5.
34. Fernández-Mestre M, Navarrete CV, Brown J, Brown C, Correa E, et al. (2009) HLA Alleles and Dengue Virus Infection in Venezuelan Patients: A Preliminary Study. Inmunología 28: 96-100.
35. Stephens HA (2010) HLA and other gene associations with dengue disease severity. Curr Top Microbiol Immunol 338: 99-114.
36. Brown M, Salas R, Vickers I, Heslop O, Smikle M (2011) Dengue HLA associations in jamaicans. West Indian Medical Journal 60: 126-131.
37. Malavige GN, Rostron T, Rohanachandra LT, Jayaratne SD, Fernando N, et al. (2011) HLA Class I and Class II Associations in Dengue Viral Infections in a Sri Lankan Population. PLoS One 6: e20581.
38. Stephens H, Klaythong R, Sirikong M, Vaughn D, Green S, et al. (2002) HLA-A and-B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 60: 309-318. (Pubitemid 36020803)
39. Loke H, Bethell DB, Phuong CXT, Dung M, Schneider J, et al. (2001) Strong HLA Class I-Restricted T Cell Responses in Dengue Hemorrhagic Fever: A Double-Edged Sword? Journal of Infectious Diseases 184: 1369-1373. (Pubitemid 33108849)
40. Kurane I, Ennis F. Immunity and immunopathology in dengue virus infections; 1992. pp. 121-127.
41. Mongkolsapaya J, Dejnirattisai W, Xu XN, Vasanawathana S, Tangthawornchaikul N, et al. (2003) Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 9: 921-927. (Pubitemid 36889936)
42. Green S, Kurane I, Pincus S, Paoletti E, Ennis FA (1997) Recognition of dengue virus NS1-NS2a proteins by human CD4+ cytotoxic T lymphocyte clones. Virology 234: 383-386. (Pubitemid 27360130)
43. Avirutnan P, Punyadee N, Noisakran S, Komoltri C, Thiemmeca S, et al. (2006) Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J Infect Dis 193: 1078-1088.
44. Gutsche I, Coulibaly F, Voss JE, Salmon J, d'Alayer J, et al. (2011) Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein. Proc Natl Acad Sci U S A 108: 8003-8008.
45. Falgout B, Chanock R, Lai C (1989) Proper processing of dengue virus nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a. J Virol 63: 1852-1860. (Pubitemid 19107777)
46. Chambers TJ, Hahn CS, Galler R, Rice CM (1990) Flavivirus Genome Organization, Expression, and Replication. Annual Review of Microbiology 44: 649-688.
47. Chaturvedi UC, Agarwal R, Elbishbishi EA, Mustafa AS (2000) Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol Med Microbiol 28: 183-188. (Pubitemid 32939398)
48. Chen L-C, Lei H-Y, Liu C-C, Shiesh S-C, Chen S-H, et al. (2006) Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. The American Journal of Tropical Medicine and Hygiene 74: 142-147. (Pubitemid 46768643)
49. Chuang Y-C, Lei H-Y, Liu H-S, Lin Y-S, Fu T-F, et al. (2011) Macrophage migration inhibitory factor induced by dengue virus infection increases vascular permeability. Cytokine 54: 222-231.
50. Assunção-Miranda I, Amaral FA, Bozza FA, Fagundes CT, Sousa LP, et al. (2010) Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection. The FASEB Journal 24: 218-228.
51. Kumar Y, Liang C, Bo Z, Rajapakse JC, Ooi EE, et al. (2012) Serum Proteome and Cytokine Analysis in a Longitudinal Cohort of Adults with Primary Dengue Infection Reveals Predictive Markers of DHF. PLoS Negl Trop Dis 6: e1887.
52. Cardier JE, Rivas B, Romano E, Rothman AL, Perez-Perez C, et al. (2006) Evidence of vascular damage in dengue disease: demonstration of high levels of soluble cell adhesion molecules and circulating endothelial cells. Endothelium 13: 335-340. (Pubitemid 44712323)
53. Khongphatthanayothin A, Phumaphuti P, Thongchaiprasit K, Poovorawan Y (2006) Serum levels of sICAM-1 and sE-selectin in patients with dengue virus infection. Jpn J Infect Dis 59: 186-188. (Pubitemid 43959978)
54. Koraka P, Murgue B, Deparis X, van Gorp E, Setiati TE, et al. (2004) Elevation of soluble VCAM-1 plasma levels in children with acute dengue virus infection of varying severity. Journal of medical virology 72: 445-450. (Pubitemid 38133985)
55. Fink J, Gu F, Ling L, Tolfvenstam T, Olfat F, et al. (2007) Host gene expression profiling of dengue virus infection in cell lines and patients. PLoS neglected tropical diseases 1: e86.
56. Perez AB, Garcia G, Sierra B, Alvarez M, Vazquez S, et al. (2004) IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba. J Med Virol 73: 230-234. (Pubitemid 38542677)
57. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, et al. (1999) Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J Med Virol 59: 329-334. (Pubitemid 29468075)
58. Cao R, Brakenhielm E, Pawliuk R, Wariaro D, Post MJ, et al. (2003) Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 9: 604-613. (Pubitemid 36597108)
59. Wanigasuriya K, Gurugama P, Wijewickrama A, Seneviratne SL, Gunatilake SB (2012) Usefulness of World Health Organization (WHO) dengue case classifications in a Sri Lankan clinical setting.